premenstrual syndrome. Premenstrual tension syndrome
Conditions
Interventions
Intervention 1: ginger Capsules, 250 mg, 2 times a day, orally for 3 months. Intervention 2: Placebo capsules, 100 mg, 2 times a day, orally for 3 months. Intervention 3: curcumin Capsules, 100 mg, 2
Treatment - Drugs
ginger Capsules, 250 mg, 2 times a day, orally for 3 months
Placebo capsules, 100 mg, 2 times a day, orally for 3 months
curcumin Capsules, 100 mg, 2 times a day, orally for 3 months
Sponsors
Nursing and Midwifery Faculty of Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Regular menstrual cycles 21-35 days, 18-35 years of age , unmarried, Physical and mental health , non-hormonal drugs, anticoagulant, antidepressants, supplements and herbal medicine, Not sensitive to turmeric and ginger , not taking any medication for the treatment of premenstrual syndrome, No alcohol or drugs, Non-traumatic stress in the last 3 months, no surgery in the last 3 months. Exclusion criteria: Unwillingness to continue participation in the study , If complications or allergic to a drug or other drug use, If stop taking the medication or taking medication irregularly , Identification of any disease such as endocrine disease, married during the study , Menstrual cycle irregularity during the study , Stressful events occurred during the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in physical symptoms (headache, breast swelling and tenderness, back pain, abdominal pain, muscle pain, weight gain, swelling of extremities, nausea, diarrhea or constipation). Timepoint: One month, two months, three months after intervention. Method of measurement: Questionnaire.;Reduction in mood symptoms (irritability and restlessness, anxiety and impatience, anger, depression and sadness, crying for no reason, feeling alone). Timepoint: One month, two months, three months after intervention. Method of measurement: Questionnaire.;Reduction in behavioral symptoms (fatigue, lack of energy, insomnia, difficulty concentrating, increased appetite). Timepoint: One month, two months, three months after intervention. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects of drugs. Timepoint: Three months after the intervention. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoomeh Kheirkhah
Nursing and Midwifery Faculty of Tehran University of Medical Sciences
Outcome results
None listed